ArticleOncotarget2016

Coexistence of YWHAZ amplification predicts better prognosis in muscle-invasive bladder cancer with CDKN2A or TP53 loss.

Shenghua Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.